Clinical Trial Update: Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating angiotensin-neprilysin inhibition as an initiation therapy for patients starting hemodialysis; the study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Angiotensin-Neprilysin inhibition (unspecified)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Hemodialysis | Phase 2 | Status: RECRUITING